Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
Launched by NOVA SCOTIA HEALTH AUTHORITY · Feb 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective virtual dietary education is for people with Irritable Bowel Syndrome (IBS). IBS is a condition that causes symptoms like abdominal pain and changes in bowel habits, which can really affect a person's daily life. The trial aims to see if providing dietary education through online sessions with a dietitian can help manage these symptoms better. Many patients struggle to access dietary support due to limited resources, and this trial explores whether using technology can bridge that gap.
To be eligible for the study, participants should be experiencing recurring abdominal pain at least once a week for the past three months and be open to changing their diet. They also need to have access to a device, like a smartphone or computer, to join virtual education sessions. Those interested can expect to receive personalized dietary advice online, either one-on-one or in groups. It's important to note that individuals with certain conditions, such as recent unexplained weight loss or inflammatory bowel disease, will not be able to participate. The trial is currently recruiting participants, and it could be a valuable opportunity for those looking for support in managing their IBS through dietary changes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recurrent abdominal pain on average at least 1 day/ week in the last 3 months associated with two or more of the following criteria: related to defecation, or association with a change in frequency of stool or associated with a change in form (appearance) of stool
- • Willingness to change diet
- • Access to a device for accessing virtual dietary education
- Exclusion Criteria:
- • New onset symptoms within past year in age 50 and above
- • Rectal bleeding
- • Inflammatory Bowel Disease
- • Unexplained recent weight loss
- • Gastrointestinal surgery with removal of gallbladder or segments of the bowel
- • Having an eating disorder
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, N.S., Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials